Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Ovarian Neoplasms"" wg kryterium: Temat


Tytuł :
The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy.
Autorzy :
van Baal JOAM; Department of Gynecology, Center for Gynecologic Oncology Amsterdam, P.O. Box 90203, Amsterdam, 1006, BE, The Netherlands. .
Lok CAR; Department of Gynecology, Center for Gynecologic Oncology Amsterdam, P.O. Box 90203, Amsterdam, 1006, BE, The Netherlands.
Jordanova ES; Department of Gynecology, Center for Gynecologic Oncology Amsterdam, P.O. Box 90203, Amsterdam, 1006, BE, The Netherlands.
Horlings H; Division of Diagnostic Oncology & Molecular Pathology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
van Driel WJ; Department of Gynecology, Center for Gynecologic Oncology Amsterdam, P.O. Box 90203, Amsterdam, 1006, BE, The Netherlands.
Amant FC; Department of Gynecology, Center for Gynecologic Oncology Amsterdam, P.O. Box 90203, Amsterdam, 1006, BE, The Netherlands.
Van de Vijver KK; Division of Diagnostic Oncology & Molecular Pathology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pathology, Ghent University Hospital, Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Pokaż więcej
Źródło :
Virchows Archiv : an international journal of pathology [Virchows Arch] 2020 Oct; Vol. 477 (4), pp. 535-544. Date of Electronic Publication: 2020 Mar 16.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Springer International Country of Publication: Germany NLM ID: 9423843 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2307 (Electronic) Linking ISSN: 09456317 NLM ISO Abbreviation: Virchows Arch Subsets: MEDLINE
MeSH Terms :
Neoadjuvant Therapy*/adverse effects
Tumor Microenvironment*
Neoplasms, Cystic, Mucinous, and Serous/*drug therapy
Neoplasms, Cystic, Mucinous, and Serous/*secondary
Ovarian Neoplasms/*drug therapy
Ovarian Neoplasms/*pathology
Peritoneal Neoplasms/*drug therapy
Peritoneal Neoplasms/*secondary
Aged ; Antigens, CD/analysis ; Antigens, Differentiation, Myelomonocytic/analysis ; CD3 Complex/analysis ; CD8-Positive T-Lymphocytes/immunology ; Cytoreduction Surgical Procedures ; Female ; Humans ; Lymphocytes, Tumor-Infiltrating/immunology ; Macrophages/immunology ; Middle Aged ; Neoplasm Grading ; Neoplasm Invasiveness ; Neoplasms, Cystic, Mucinous, and Serous/immunology ; Neoplasms, Cystic, Mucinous, and Serous/mortality ; Ovarian Neoplasms/immunology ; Ovarian Neoplasms/mortality ; Peritoneal Neoplasms/immunology ; Peritoneal Neoplasms/mortality ; Prospective Studies ; Receptors, Cell Surface/analysis ; Retrospective Studies ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Clinicopathological and survival characteristic of mismatch repair status in ovarian clear cell carcinoma.
Autorzy :
Zhu J; Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Ke G; Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Bi R; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
Wu X; Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2020 Sep; Vol. 122 (3), pp. 538-546. Date of Electronic Publication: 2020 May 12.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE
MeSH Terms :
DNA Mismatch Repair*
Adenocarcinoma, Clear Cell/*genetics
Adenocarcinoma, Clear Cell/*pathology
Carcinoma, Ovarian Epithelial/*genetics
Carcinoma, Ovarian Epithelial/*pathology
Ovarian Neoplasms/*genetics
Ovarian Neoplasms/*pathology
Adenocarcinoma, Clear Cell/metabolism ; Adenocarcinoma, Clear Cell/mortality ; Carcinoma, Ovarian Epithelial/metabolism ; Carcinoma, Ovarian Epithelial/mortality ; DNA-Binding Proteins/biosynthesis ; Female ; Humans ; Immunohistochemistry ; Middle Aged ; Mismatch Repair Endonuclease PMS2/biosynthesis ; MutL Protein Homolog 1/biosynthesis ; MutS Homolog 2 Protein/biosynthesis ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/mortality ; Tissue Array Analysis
Czasopismo naukowe
Tytuł :
FoxM1 promotes the migration of ovarian cancer cell through KRT5 and KRT7.
Autorzy :
Zhang Z; Key Laboratory of Women's Reproductive Health of Jiangxi, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, PR China; Central Laboratory, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, PR China.
Tu K; Department of Oncology, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, PR China.
Liu F; Key Laboratory of Women's Reproductive Health of Jiangxi, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, PR China; Central Laboratory, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, PR China.
Liang M; Department of Oncology, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, PR China.
Yu K; The College of Medicine, Nanchang University, Nanchang, Jiangxi 330006, PR China.
Wang Y; The College of Medicine, Nanchang University, Nanchang, Jiangxi 330006, PR China.
Luo Y; Key Laboratory of Women's Reproductive Health of Jiangxi, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, PR China; Central Laboratory, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, PR China.
Yang B; Key Laboratory of Women's Reproductive Health of Jiangxi, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, PR China; Central Laboratory, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, PR China.
Qin Y; Department of Pathology, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, PR China.
He D; Department of Pathology, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, PR China.
Jiang G; Department of Obstetrics, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, 330006, PR China.
Huang O; Key Laboratory of Women's Reproductive Health of Jiangxi, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, PR China; Central Laboratory, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, PR China. Electronic address: .
Zou Y; Key Laboratory of Women's Reproductive Health of Jiangxi, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, PR China; Central Laboratory, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, PR China. Electronic address: .
Pokaż więcej
Źródło :
Gene [Gene] 2020 Oct 05; Vol. 757, pp. 144947. Date of Electronic Publication: 2020 Jul 10.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 7706761 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0038 (Electronic) Linking ISSN: 03781119 NLM ISO Abbreviation: Gene Subsets: MEDLINE
MeSH Terms :
Cell Movement*
Forkhead Box Protein M1/*metabolism
Keratin-5/*metabolism
Keratin-7/*metabolism
Ovarian Neoplasms/*genetics
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Cell Line, Tumor ; Female ; Forkhead Box Protein M1/genetics ; Humans ; Keratin-5/genetics ; Keratin-7/genetics ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Primary ovarian carcinoid: Two cases report and review of literature.
Autorzy :
Zhai LR; Department of gynecology and Obstetrics.
Zhang XW; Department of gynecology and Obstetrics.
Yu T; Department of Orthopaedics.
Jiang ZD; Department of Orthopaedics.
Huang DW; Department of Pathology, The Second Hospital of Jilin University, Changchun, Jilin Province, China.
Jia Y; Department of gynecology and Obstetrics.
Cui MH; Department of gynecology and Obstetrics.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Oct 02; Vol. 99 (40), pp. e21109.
Typ publikacji :
Case Reports; Journal Article; Review
Journal Info :
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Carcinoid Tumor/*pathology
Ovarian Neoplasms/*pathology
Carcinoid Tumor/diagnostic imaging ; Carcinoid Tumor/surgery ; Female ; Humans ; Hysterectomy ; Middle Aged ; Ovarian Neoplasms/diagnostic imaging ; Ovarian Neoplasms/surgery ; Salpingo-oophorectomy ; Tomography, X-Ray Computed ; Treatment Outcome ; Ultrasonography
Czasopismo naukowe
Tytuł :
Azidothymidine (AZT) Inhibits Proliferation of Human Ovarian Cancer Cells by Regulating Cell Cycle Progression.
Autorzy :
Hsieh Y; Department of Obstetrics, Gynecology and Women's Health, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
Tseng JJ; Department of Obstetrics, Gynecology and Women's Health, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C. .
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2020 Oct; Vol. 40 (10), pp. 5517-5527.
Typ publikacji :
Journal Article
Journal Info :
Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE
MeSH Terms :
Cell Cycle/*drug effects
Cell Proliferation/*drug effects
Ovarian Neoplasms/*drug therapy
Zidovudine/*pharmacology
Apoptosis/drug effects ; Cell Cycle Checkpoints/drug effects ; Cell Division/drug effects ; Cell Line, Tumor ; Female ; Humans ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Radical Surgical Procedures in Advanced Ovarian Cancer and Differences Between Primary and Interval Debulking Surgery.
Autorzy :
Mitsopoulos V; Gynecological Oncology Department, Poole Hospital NHS Trust, Poole, U.K.
Innamaa A; Gynecological Oncology Department, Poole Hospital NHS Trust, Poole, U.K.
Lippiatt J; Gynecological Oncology Department, Poole Hospital NHS Trust, Poole, U.K.
Plevris N; Gynecological Oncology Department, Poole Hospital NHS Trust, Poole, U.K.
Biliatis I; Gynecological Oncology Department, Poole Hospital NHS Trust, Poole, U.K. .
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2020 Oct; Vol. 40 (10), pp. 5869-5875.
Typ publikacji :
Journal Article
Journal Info :
Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE
MeSH Terms :
Cytoreduction Surgical Procedures*
Ovarian Neoplasms/*surgery
Ovary/*surgery
Aged ; Antineoplastic Combined Chemotherapy Protocols ; Chemotherapy, Adjuvant ; Female ; Humans ; Length of Stay ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Staging ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/pathology ; Ovary/pathology
Czasopismo naukowe
Tytuł :
Integrity of plasma DNA is inversely correlated with vaccine-induced antitumor immunity in ovarian cancer patients.
Autorzy :
Waki K; Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka, 830-0011, Japan.
Yokomizo K; Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka, 830-0011, Japan.
Kawano K; Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Tsuda N; Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Komatsu N; Department of Immunology, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Yamada A; Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka, 830-0011, Japan. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Oct; Vol. 69 (10), pp. 2001-2007. Date of Electronic Publication: 2020 May 11.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
MeSH Terms :
Biomarkers, Tumor/*immunology
Cancer Vaccines/*immunology
Carcinoma, Ovarian Epithelial/*immunology
Circulating Tumor DNA/*blood
Neoplasm Recurrence, Local/*immunology
Ovarian Neoplasms/*immunology
Vaccines, Subunit/*immunology
Cancer Vaccines/administration & dosage ; Carcinoma, Ovarian Epithelial/blood ; Carcinoma, Ovarian Epithelial/genetics ; Circulating Tumor DNA/genetics ; Female ; Follow-Up Studies ; Humans ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/genetics ; Ovarian Neoplasms/blood ; Ovarian Neoplasms/genetics ; Prognosis ; Vaccines, Subunit/administration & dosage
Czasopismo naukowe
Tytuł :
m A Regulator TRMT10C Predicts Poorer Survival and Contributes to Malignant Behavior in Gynecological Cancers.
Autorzy :
Wang Q; Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, P.R. China.
Zhang Q; Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai, P.R. China.
Huang Y; School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, P.R. China.
Zhang J; Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, P.R. China.
Pokaż więcej
Źródło :
DNA and cell biology [DNA Cell Biol] 2020 Oct; Vol. 39 (10), pp. 1767-1778. Date of Electronic Publication: 2020 Aug 21.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 9004522 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-7430 (Electronic) Linking ISSN: 10445498 NLM ISO Abbreviation: DNA Cell Biol Subsets: MEDLINE
MeSH Terms :
Biomarkers, Tumor/*genetics
Methyltransferases/*genetics
Ovarian Neoplasms/*genetics
Uterine Cervical Neoplasms/*genetics
Adenosine/analogs & derivatives ; Adenosine/metabolism ; Biomarkers, Tumor/metabolism ; Cell Movement ; Cell Proliferation ; Female ; HeLa Cells ; Humans ; Methyltransferases/metabolism ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/pathology ; Uterine Cervical Neoplasms/metabolism ; Uterine Cervical Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer.
Autorzy :
Kaltofen T; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany. .
Preinfalk V; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.
Schwertler S; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.
Fraungruber P; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.
Heidegger H; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.
Vilsmaier T; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.
Vattai A; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.
Czogalla B; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.
Mayr D; Department of Pathology, University Hospital, LMU Munich, Munich, Germany.
Mahner S; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.
Jeschke U; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.; Department of Obstetrics and Gynecology, University Hospital Augsburg, Augsburg, Germany.
Trillsch F; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Oct; Vol. 146 (10), pp. 2559-2574. Date of Electronic Publication: 2020 Jul 17.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J. Cancer Res. Clin. Oncol. Subsets: MEDLINE
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*pharmacology
Carcinoma, Ovarian Epithelial/*drug therapy
Carcinoma, Ovarian Epithelial/*metabolism
Organoplatinum Compounds/*pharmacology
Ovarian Neoplasms/*drug therapy
Ovarian Neoplasms/*metabolism
Wnt Signaling Pathway/*drug effects
Antigens, CD/biosynthesis ; Antigens, CD/metabolism ; Cadherins/biosynthesis ; Cadherins/metabolism ; Carcinoma, Ovarian Epithelial/pathology ; Cell Line, Tumor ; Cell Movement/drug effects ; Diterpenes/pharmacology ; Drug Resistance, Neoplasm ; Epoxy Compounds/pharmacology ; Female ; Heterocyclic Compounds, 3-Ring/pharmacology ; Humans ; Indoles/pharmacology ; Maleimides/pharmacology ; Middle Aged ; Neoplasm Staging ; Organoplatinum Compounds/administration & dosage ; Ovarian Neoplasms/pathology ; Phenanthrenes/pharmacology ; beta Catenin/biosynthesis ; beta Catenin/metabolism
Czasopismo naukowe
Tytuł :
Patterns of clinicopathological features and outcome in epithelial ovarian cancer patients: 35 years of prospectively collected data.
Autorzy :
Irodi A; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Rye T; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Herbert K; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.; Oxford Cancer Centre, Churchill Hospital, Oxford, UK.
Churchman M; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Bartos C; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Mackean M; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.
Nussey F; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.
Herrington CS; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Gourley C; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Hollis RL; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Pokaż więcej
Źródło :
BJOG : an international journal of obstetrics and gynaecology [BJOG] 2020 Oct; Vol. 127 (11), pp. 1409-1420. Date of Electronic Publication: 2020 May 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100935741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-0528 (Electronic) Linking ISSN: 14700328 NLM ISO Abbreviation: BJOG Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Carcinoma, Ovarian Epithelial/*mortality
Carcinoma, Ovarian Epithelial/*pathology
Ovarian Neoplasms/*mortality
Ovarian Neoplasms/*pathology
Age of Onset ; Carcinoma, Ovarian Epithelial/surgery ; Cytoreduction Surgical Procedures ; Female ; Humans ; Kaplan-Meier Estimate ; Neoplasm Grading ; Neoplasm Staging ; Ovarian Neoplasms/surgery ; Progression-Free Survival ; Registries ; Retrospective Studies ; Scotland/epidemiology
Czasopismo naukowe
Tytuł :
Pediatric growing teratoma syndrome of the ovary: A case report and review of the literature.
Autorzy :
Oyama T; Department of Pediatric Surgery.
Noda T; Department of Pediatric Surgery.
Washio K; Department of Pediatrics, Okayama University Hospital, Okayama, Japan.
Shimada A; Department of Pediatrics, Okayama University Hospital, Okayama, Japan.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Sep 18; Vol. 99 (38), pp. e22297.
Typ publikacji :
Case Reports; Journal Article; Review
Journal Info :
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Ovarian Neoplasms/*therapy
Salpingo-oophorectomy/*methods
Teratoma/*therapy
Bleomycin/therapeutic use ; Child ; Cisplatin/therapeutic use ; Etoposide/therapeutic use ; Female ; Humans ; Neoplasm Grading ; Neoplasm Recurrence, Local ; Ovarian Neoplasms/diagnostic imaging ; Ovarian Neoplasms/pathology ; Positron Emission Tomography Computed Tomography ; Syndrome ; Teratoma/diagnostic imaging ; Teratoma/pathology
SCR Disease Name :
Teratoma, Ovarian
SCR Protocol :
BEP protocol
Czasopismo naukowe
Tytuł :
Feasibility of neoadjuvant and adjuvant intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancer: A single-center experience.
Autorzy :
Liu Y; Department of Obstetrics and Gynecology of the First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing, China.
Cao L
Chen W
Wang J
Wang W
Liang Z
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Sep 04; Vol. 99 (36), pp. e22100.
Typ publikacji :
Journal Article; Observational Study
Journal Info :
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma, Ovarian Epithelial/*drug therapy
Ovarian Neoplasms/*drug therapy
Adult ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Body Mass Index ; Carcinoma, Ovarian Epithelial/mortality ; Carcinoma, Ovarian Epithelial/pathology ; Carcinoma, Ovarian Epithelial/therapy ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Female ; Humans ; Infusions, Parenteral ; Kaplan-Meier Estimate ; Middle Aged ; Ovarian Neoplasms/mortality ; Ovarian Neoplasms/pathology ; Ovarian Neoplasms/therapy ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Continuous Administration of Bevacizumab After Disease Progression in Recurrent Ovarian Cancer: A Retrospective Observational Study.
Autorzy :
Tanigawa T; Cancer Institute Hospital, Tokyo, Japan .
Matoda M; Cancer Institute Hospital, Tokyo, Japan.
Omi M; Cancer Institute Hospital, Tokyo, Japan.
Aoki Y; Cancer Institute Hospital, Tokyo, Japan.
Netsu S; Cancer Institute Hospital, Tokyo, Japan.
Nomura H; Cancer Institute Hospital, Tokyo, Japan.
Okamoto S; Cancer Institute Hospital, Tokyo, Japan.
Omatsu K; Cancer Institute Hospital, Tokyo, Japan.
Yunokawa M; Cancer Institute Hospital, Tokyo, Japan.
Kanao H; Cancer Institute Hospital, Tokyo, Japan.
Takeshima N; Cancer Institute Hospital, Tokyo, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2020 Sep; Vol. 40 (9), pp. 5285-5290.
Typ publikacji :
Journal Article
Journal Info :
Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res. Subsets: MEDLINE
MeSH Terms :
Angiogenesis Inhibitors/*administration & dosage
Antineoplastic Agents, Immunological/*administration & dosage
Bevacizumab/*administration & dosage
Ovarian Neoplasms/*drug therapy
Ovarian Neoplasms/*pathology
Adult ; Aged ; Disease Progression ; Female ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Neoplasm Staging ; Ovarian Neoplasms/mortality ; Prognosis ; Recurrence ; Retreatment ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
State of the art and up-and-coming angiogenesis inhibitors for ovarian cancer.
Autorzy :
Singh N; Tom Baker Cancer Centre, Gynecologic Oncology , Calgary, Alberta, Canada.
Badrun D; Tom Baker Cancer Centre, Gynecologic Oncology , Calgary, Alberta, Canada.
Ghatage P; Tom Baker Cancer Centre, Gynecologic Oncology , Calgary, Alberta, Canada.
Pokaż więcej
Źródło :
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2020 Sep; Vol. 21 (13), pp. 1579-1590. Date of Electronic Publication: 2020 Jun 17.
Typ publikacji :
Journal Article; Review
Journal Info :
Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7666 (Electronic) Linking ISSN: 14656566 NLM ISO Abbreviation: Expert Opin Pharmacother Subsets: MEDLINE
MeSH Terms :
Angiogenesis Inhibitors/*therapeutic use
Bevacizumab/*therapeutic use
Carcinoma, Ovarian Epithelial/*drug therapy
Neovascularization, Pathologic/*drug therapy
Ovarian Neoplasms/*drug therapy
Carcinoma, Ovarian Epithelial/blood supply ; Carcinoma, Ovarian Epithelial/mortality ; Clinical Trials as Topic ; Female ; Humans ; Ovarian Neoplasms/blood supply ; Ovarian Neoplasms/mortality ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Cabazitaxel - A Treatment Option in Recurrent Platinum-resistant Ovarian Cancer.
Autorzy :
Madsen CV; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark .
Adimi P; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.
Jakobsen A; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Institute of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Steffensen KD; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Institute of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2020 Sep; Vol. 40 (9), pp. 5255-5261.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
Journal Info :
Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res. Subsets: MEDLINE
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Ovarian Neoplasms/*drug therapy
Ovarian Neoplasms/*pathology
Taxoids/*therapeutic use
Adult ; Aged ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/adverse effects ; Drug Administration Schedule ; Drug Resistance, Neoplasm ; Female ; Humans ; Middle Aged ; Neoplasm Staging ; Ovarian Neoplasms/mortality ; Prognosis ; Quality of Life ; Recurrence ; Retreatment ; Taxoids/administration & dosage ; Taxoids/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Association of gBRCA1/2 mutation locations with ovarian cancer risk in Japanese patients from the CHARLOTTE study.
Autorzy :
Yoshihara K; Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Enomoto T; Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Aoki D; Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
Watanabe Y; Department of Obstetrics and Gynecology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Kigawa J; Department of Obstetrics and Gynecology, Matsue City Hospital, Matsue, Japan.
Takeshima N; Department of Gynecology, Cancer Institute Hospital, Tokyo, Japan.
Inomata H; Medical Department, AstraZeneca K.K., Osaka, Japan.
Hattori K; Medical Department, AstraZeneca K.K., Osaka, Japan.
Jinushi M; Medical Department, AstraZeneca K.K., Osaka, Japan.
Tsuda H; Department of Basic Pathology, National Defense Medical College, Tokorozawa, Japan.
Sugiyama T; Department of Obstetrics and Gynecology, St. Mary's Hospital, Kurume, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2020 Sep; Vol. 111 (9), pp. 3350-3358. Date of Electronic Publication: 2020 Aug 02.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci. Subsets: MEDLINE
MeSH Terms :
Genetic Predisposition to Disease*
Mutation*
BRCA1 Protein/*genetics
BRCA2 Protein/*genetics
Ovarian Neoplasms/*epidemiology
Ovarian Neoplasms/*genetics
Adult ; Aged ; Cross-Sectional Studies ; Female ; Genetic Association Studies ; Genetic Testing ; Humans ; Middle Aged ; Mutation Rate ; Ovarian Neoplasms/pathology ; Prevalence ; Young Adult
Czasopismo naukowe
Tytuł :
Expression of ACAP1 Is Associated with Tumor Immune Infiltration and Clinical Outcome of Ovarian Cancer.
Autorzy :
Zhang J; Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Zhang Q; Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai, China.
Zhang J; Department of Integrated Therapy, Shanghai Cancer Center, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Wang Q; Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Pokaż więcej
Źródło :
DNA and cell biology [DNA Cell Biol] 2020 Sep; Vol. 39 (9), pp. 1545-1557. Date of Electronic Publication: 2020 May 22.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 9004522 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-7430 (Electronic) Linking ISSN: 10445498 NLM ISO Abbreviation: DNA Cell Biol. Subsets: MEDLINE
MeSH Terms :
Biomarkers, Tumor/*genetics
GTPase-Activating Proteins/*genetics
Ovarian Neoplasms/*genetics
Biomarkers, Tumor/metabolism ; Cell Differentiation ; Chemokines/genetics ; Chemokines/metabolism ; DNA Methylation ; Female ; GTPase-Activating Proteins/metabolism ; Humans ; Lymphocytes, Tumor-Infiltrating/metabolism ; Neoplastic Stem Cells/metabolism ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/pathology ; Survival Analysis ; Tumor Microenvironment ; Up-Regulation
Czasopismo naukowe
Tytuł :
Nanoparticle Ovarian Carcinoma.
Autorzy :
Gong K; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, People's Republic of China.
Dong Y; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, People's Republic of China.
Wang L; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, People's Republic of China.
Duan Y; Department of Clinical Medicine, North Sichuan Medical College, Sichuan 637100, People's Republic of China.
Yu J; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, People's Republic of China.
Sun Y; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, People's Republic of China.
Bai M; Department of Ultrasound, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, People's Republic of China.
Duan Y; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, People's Republic of China.
Pokaż więcej
Źródło :
International journal of nanomedicine [Int J Nanomedicine] 2020 Aug 04; Vol. 15, pp. 5561-5571. Date of Electronic Publication: 2020 Aug 04 (Print Publication: 2020).
Typ publikacji :
Journal Article
Journal Info :
Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2013 (Electronic) Linking ISSN: 11769114 NLM ISO Abbreviation: Int J Nanomedicine Subsets: MEDLINE
MeSH Terms :
Azetidines/*administration & dosage
Benzyl Compounds/*administration & dosage
Drug Resistance, Neoplasm/*drug effects
Nanoparticles/*chemistry
Ovarian Neoplasms/*drug therapy
STAT3 Transcription Factor/*antagonists & inhibitors
Sphingosine-1-Phosphate Receptors/*genetics
Azetidines/pharmacokinetics ; Benzyl Compounds/pharmacokinetics ; Calcium Phosphates/chemistry ; Cell Line, Tumor ; Cisplatin/therapeutic use ; Drug Delivery Systems ; Drug Resistance, Neoplasm/genetics ; Female ; Humans ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/pathology ; Phosphorylation/drug effects ; Polyethylene Glycols/chemistry ; STAT3 Transcription Factor/metabolism ; Sphingosine-1-Phosphate Receptors/antagonists & inhibitors ; Sphingosine-1-Phosphate Receptors/metabolism
Czasopismo naukowe
Tytuł :
Anti-NMDA receptor encephalitis associated with ovarian tumor: the gynecologist point of view.
Autorzy :
Delangle R; Department of Gynecologic and Breast Surgery and Oncology, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière, Charles Foix, 47/83 Boulevard de l'Hôpital, 75013, Paris, France.
Demeret S; Department of Neurology, AP-HP, Pitié-Salpêtrière University Hospital, 75013, Paris, France.
Canlorbe G; Department of Gynecologic and Breast Surgery and Oncology, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière, Charles Foix, 47/83 Boulevard de l'Hôpital, 75013, Paris, France.
Chelon L; Department of Gynecologic and Breast Surgery and Oncology, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière, Charles Foix, 47/83 Boulevard de l'Hôpital, 75013, Paris, France.
Belghiti J; Department of Gynecologic and Breast Surgery and Oncology, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière, Charles Foix, 47/83 Boulevard de l'Hôpital, 75013, Paris, France.
Gonthier C; Department of Gynecologic and Breast Surgery and Oncology, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière, Charles Foix, 47/83 Boulevard de l'Hôpital, 75013, Paris, France.
Nikpayam M; Department of Gynecologic and Breast Surgery and Oncology, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière, Charles Foix, 47/83 Boulevard de l'Hôpital, 75013, Paris, France.
Uzan C; Department of Gynecologic and Breast Surgery and Oncology, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière, Charles Foix, 47/83 Boulevard de l'Hôpital, 75013, Paris, France.
Azaïs H; Department of Gynecologic and Breast Surgery and Oncology, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière, Charles Foix, 47/83 Boulevard de l'Hôpital, 75013, Paris, France. .
Pokaż więcej
Źródło :
Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2020 Aug; Vol. 302 (2), pp. 315-320. Date of Electronic Publication: 2020 Jun 17.
Typ publikacji :
Journal Article; Review
Journal Info :
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8710213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0711 (Electronic) Linking ISSN: 09320067 NLM ISO Abbreviation: Arch. Gynecol. Obstet. Subsets: MEDLINE
MeSH Terms :
Anti-N-Methyl-D-Aspartate Receptor Encephalitis*/diagnosis
Anti-N-Methyl-D-Aspartate Receptor Encephalitis*/epidemiology
Anti-N-Methyl-D-Aspartate Receptor Encephalitis*/therapy
Antibodies/*cerebrospinal fluid
Ovarian Neoplasms/*complications
Receptors, N-Methyl-D-Aspartate/*immunology
Teratoma/*complications
Adult ; Female ; Humans ; Ovarian Neoplasms/pathology ; Ovarian Neoplasms/surgery ; Physical Examination ; Prognosis ; Reproduction ; Teratoma/pathology ; Teratoma/surgery ; Young Adult
SCR Disease Name :
Teratoma, Ovarian
Czasopismo naukowe
Tytuł :
Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade.
Autorzy :
Natoli M; Department of Surgery and Cancer, Institute of Reproductive and Developmental Biology, Imperial College London, London, UK.
Bonito N; Department of Surgery and Cancer, Institute of Reproductive and Developmental Biology, Imperial College London, London, UK.
Robinson JD; Mechanistic Biology and Profiling, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
Ghaem-Maghami S; Department of Surgery and Cancer, Institute of Reproductive and Developmental Biology, Imperial College London, London, UK. .
Mao Y; Bioscience, Early Oncology R&D, AstraZeneca, Cambridge, UK. .; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Aug; Vol. 69 (8), pp. 1391-1401. Date of Electronic Publication: 2020 Mar 21.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol. Immunother. Subsets: MEDLINE
MeSH Terms :
Apoptosis*
B7-H1 Antigen/*antagonists & inhibitors
Lymphocyte Activation/*immunology
Nivolumab/*pharmacology
Ovarian Neoplasms/*immunology
Programmed Cell Death 1 Receptor/*antagonists & inhibitors
Antineoplastic Agents, Immunological/pharmacology ; Biomarkers, Tumor ; Cell Proliferation ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Lymphocyte Activation/drug effects ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/pathology ; Prognosis ; Tumor Cells, Cultured
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies